Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2010 2
2011 3
2012 2
2013 1
2014 1
2018 2
2019 3
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
From fiction to science: clinical potentials and regulatory considerations of gene editing.
Schacker M, Seimetz D. Schacker M, et al. Among authors: seimetz d. Clin Transl Med. 2019 Oct 21;8(1):27. doi: 10.1186/s40169-019-0244-7. Clin Transl Med. 2019. PMID: 31637541 Free PMC article. Review.
Approval of First CAR-Ts: Have we Solved all Hurdles for ATMPs?
Seimetz D, Heller K, Richter J. Seimetz D, et al. Cell Med. 2019 Jan 22;11:2155179018822781. doi: 10.1177/2155179018822781. eCollection 2019. Cell Med. 2019. PMID: 32634192 Free PMC article. Review.
Expediting Drug Development: FDA's New Regenerative Medicine Advanced Therapy Designation.
Vaggelas A, Seimetz D. Vaggelas A, et al. Among authors: seimetz d. Ther Innov Regul Sci. 2019 May;53(3):364-373. doi: 10.1177/2168479018779373. Epub 2018 Jun 12. Ther Innov Regul Sci. 2019. PMID: 29895180
Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies.
Piaggesi A, Låuchli S, Bassetto F, Biedermann T, Marques A, Najafi B, Palla I, Scarpa C, Seimetz D, Triulzi I, Turchetti G, Vaggelas A. Piaggesi A, et al. Among authors: seimetz d. J Wound Care. 2018 Jun 1;27(Sup6a):S1-S137. doi: 10.12968/jowc.2018.27.Sup6a.S1. J Wound Care. 2018. PMID: 29902114 Review. No abstract available.
Catumaxomab: clinical development and future directions.
Linke R, Klein A, Seimetz D. Linke R, et al. Among authors: seimetz d. MAbs. 2010 Mar-Apr;2(2):129-36. doi: 10.4161/mabs.2.2.11221. MAbs. 2010. PMID: 20190561 Free PMC article. Review.
Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy.
Seimetz D, Lindhofer H, Bokemeyer C. Seimetz D, et al. Cancer Treat Rev. 2010 Oct;36(6):458-67. doi: 10.1016/j.ctrv.2010.03.001. Epub 2010 Mar 27. Cancer Treat Rev. 2010. PMID: 20347527 Review.
19th Annual Meeting of the Safety Pharmacology Society: regulatory and safety perspectives for advanced therapy medicinal products (cellular and gene therapy products).
Cavero I, Seimetz D, Koziel D, Zimmermann WH, Holzgrefe HH. Cavero I, et al. Among authors: seimetz d. Expert Opin Drug Saf. 2020 May;19(5):553-558. doi: 10.1080/14740338.2020.1741546. Epub 2020 Mar 20. Expert Opin Drug Saf. 2020. PMID: 32163309
Novel monoclonal antibodies for cancer treatment: the trifunctional antibody catumaxomab (removab).
Seimetz D. Seimetz D. J Cancer. 2011;2:309-16. doi: 10.7150/jca.2.309. Epub 2011 May 25. J Cancer. 2011. PMID: 21716847 Free PMC article.
The role of relative lymphocyte count as a biomarker for the effect of catumaxomab on survival in malignant ascites patients: results from a phase II/III study.
Heiss MM, Ströhlein MA, Bokemeyer C, Arnold D, Parsons SL, Seimetz D, Lindhofer H, Schulze E, Hennig M. Heiss MM, et al. Among authors: seimetz d. Clin Cancer Res. 2014 Jun 15;20(12):3348-57. doi: 10.1158/1078-0432.CCR-13-2351. Epub 2014 Apr 8. Clin Cancer Res. 2014. PMID: 24714773 Free article. Clinical Trial.
The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting.
Atanackovic D, Reinhard H, Meyer S, Spöck S, Grob T, Luetkens T, Yousef S, Cao Y, Hildebrandt Y, Templin J, Bartels K, Lajmi N, Stoiber H, Kröger N, Atz J, Seimetz D, Izbicki JR, Bokemeyer C. Atanackovic D, et al. Among authors: seimetz d. Hum Vaccin Immunother. 2013 Dec;9(12):2533-42. doi: 10.4161/hv.26065. Epub 2013 Aug 16. Hum Vaccin Immunother. 2013. PMID: 23955093 Free PMC article. Clinical Trial.
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback